Alerts

Recall of lactated ringer's injection and 0.9% sodium chloride injection by ICU Medical due to particulate matter.

Recall of Echelon Flex Endopath Staplers by Ethicon due to incompletely formed staples.

Recall of ranitidine syrup, 15 mg/mL by Lannett due to too much NDMA.

Recall of alprazolam tablets by Mylan Pharmaceuticals Recall due to potential contamination.

Recall of ranitidine by Novitium Pharma due to impurity.

Recall of ranitidine by Perrigo Company due to possible contamination.

Recall of ranitidine products by Dr. Reddy’s due to contamination.

Recall of Zantac 150, Zantac 150 Cool Mint, Zantac 75 (OTC products) by Sanofi due to impurity.

Recall of Green Lumber (dietary supplements for male sexual enhancement) capsule packages by GL Holdings due to undeclared tadalafil.

Recall of Johnson’s Baby Powder by Johnson & Johnson due to contamination.

Recall of Sterile Injectables by Viatrexx Bio Incorporated due to lack of sterility assurance.

Recall of Humate-P [Antihemophilic Factor/von Willebrand Factor Complex (Human)] by CSL Behring due to packaging error.

Recall of all sterile compounded drug products by Innoveix Pharmaceuticals due to lack of sterility assurance.

Recall of certain lots of Plum and Sapphire microbore infusion sets with inline filters by ICU Medical due to leaking potential.

Recall of 6 French Sherpa NX active guide catheters by Medtronic due to separation and fragmentation.

The use of tetrahydrocannabinol (THC) vaping products, particularly those containing vitamin E acetate, may cause respiratory illnesses. FDA is now warning consumers to stop using all vaping products containing THC.

Recall of LemonPrep tubes and single use cups by Mavidon due to burkholderia cepacia contamination.

Recall of ranitidine tablets, 75 mg and 150 mg by Apotex due to impurity.

Recall of Infusomat Space Volumetric infusion pump administration set by B. Braun Medical due to leak potential.

Recall of ranitidine hydrochloride capsules, 150mg and 300mg by Sandoz due to impurity.

Recall of losartan potassium tablets USP and losartan potassium/hydrochlorothiazide tablets USP by Torrent Pharmaceuticals due to detection of n-methylnitrosobutyric acid (NMBA).

Voluntarily recalled tablets of losartan potassium co-formulated with hydrochlorothiazide.

Recall of Mero Macho artificial passion fruit flavored vitamin C liquid supplement by Fitoterapia due to presence of tadalafil.

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors can cause lung inflammation when used to treat advanced breast cancers.